Enhancing Oncology Research with built-in KRAS Assay products and services and RAS Assays
within the quickly evolving area of oncology research, precise and successful mutation screening is essential for creating specific therapies. The KRAS products and services Platform plays a pivotal job Within this landscape by offering extensive options for KRAS mutation profiling and Investigation. KRAS mutations, present in close to 95% of RAS-l